Suchergebnisse - (Person:"Scarsi, Mirko")

PubPharm (5)

1

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2016

von Piantoni, S. | Colombo, E. | Tincani, A. | +2

2

Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients

enthalten in: Journal of translational medicine | 2015

von Imberti, L. | Scarsi, M. | Zanotti, C. | +4

3

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2014

von Scarsi, M. | Paolini, L. | Ricotta, D. | +5

CommentIn: J Rheumatol. 2014 May;41(5):825-8. - PMID 24692519

4

Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2011

von Scarsi, M. | Ziglioli, T. | Airo', P.

5

Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response

enthalten in: The Journal of rheumatology | 2010

von Scarsi, M. | Ziglioli, T. | Airò, P.

1
[1]